… in medical history for James Parkinson's by addition of more symptoms to … Parkinson's
disease (PD) for those symptoms [4]. Being the second most familiar ND after Alzheimer's disease …

… The degenerative disease like Parkinson's disease (PD) … , we show Parkinson's disease
combined with rising nanoparticles, … Gold nano-rods are found to hold huge prospects to supply …

… Parkinson disease: Factors influencing the development of molecular alterations leading to
Parkinson disease… -co-glycolide) acid nanoparticles targeting nose to brain delivery were …

… Current therapies for Parkinson's disease are symptomatic … In the last decade, micro-
and nanoparticles have proved to … of new strategies against Parkinson's disease. The list of …

… nanoparticles that may impact on future PD therapies. We will first describe the composition
and structure of the various subtypes of nanoparticles … We will then outline how nanoparticles …

… Parkinson's disease is a neurodegenerative disease, the … metal and metal oxide nanoparticles
have been employed to assist … deficits associated with Parkinson's disease, and involves …

… The encapsulation efficacy of these nanoparticles was 50%. The … to the effective passage
of nanoparticles to the brain [59]. … This paper also elucidated the future prospects of NDDS in …

Background Parkinson’s disease (PD) is the most common progressive neurodegenerative
disorder and is characterized by the degeneration of dopamine (DA) neurons in the …

… In summary, a therapeutic intervention aimed at treating Parkinson's disease optimally
could have an effect lasting years, and be targeted to the nigrostriatal pathway, either through …

… For example, same of these common features are presented in the main NDs such as;
Parkinson's Diseases (PD), Alzheimer's disease (AD), Huntington disease (HD), or amyotrophic …